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Novel CYP2E1 haplotype identified in a 
South African cohort
Alcohol abuse accounts for approximately 2.5 million deaths annually and is the third highest risk factor 
for disease and disability. Alcohol is metabolised by polymorphic enzymes and the status of an individual 
with respect to alcohol metabolising enzymes may have forensic relevance in post-mortems. Baseline 
frequencies of gene variants involved in alcohol metabolism need to be established to aid the identification 
of suitable population-specific polymorphisms to genotype during molecular autopsies. The principal 
alcohol metabolising enzymes include alcohol dehydrogenase (ADH), aldehyde dehydrogenase (ALDH) 
and cytochrome P450 2E1 (CYP2E1). Six single nucleotide polymorphisms (SNPs) – rs1229984G>A and 
rs2066702C>T in ADH1B, rs671G>A in ALDH2, and rs3813867G>C, rs2031920C>T and rs6413432T>A 
in CYP2E1 – were genotyped in 150 individuals from four South African populations: Xhosa, Zulu, South 
African white and South African coloured. Allele frequencies for each SNP in the four population groups 
were 0–10% for rs1229984A, 2–12% for rs2066702T, 0–2% for rs671A, 1–4% for rs3813867C, 0–1% 
for rs2031920T and 3–15% for rs6413432A. Haplotype analysis revealed a novel combination of three 
SNPs in CYP2E1 whose effects on alcohol metabolism need further investigation. Establishment of baseline 
frequencies adds to our knowledge of genetic variation in alcohol metabolising enzymes and additional 
research is required to determine the functional significance of this novel CYP2E1 haplotype. 
Introduction
Alcohol abuse accounts for nearly 2.5 million deaths annually and contributes to about 4% of all global deaths.1 
On average, 31% of South Africa’s population consume alcohol; and the total amount of alcohol consumed per 
capita is one of the highest in the world.2 Alcohol is the leading abused substance for the majority of South African 
citizens3 and contributes to more than 60 different types of injuries and diseases1.
Alcohol metabolism can significantly influence drinking behaviour as well as the risk of alcohol dependence.4,5 
Ethanol, the main component of alcohol, is primarily converted to acetaldehyde by alcohol dehydrogenases (ADHs). 
However, ADH enzymes are easily saturated, especially in chronic alcohol consumers, and, in such cases, two 
additional families of enzymes – cytochrome P450 family 2 subfamily E polypeptide 1 (CYP2E1) and, to a lesser 
extent, catalase (CAT) – become involved. Acetaldehyde is then converted to acetate via the mitochondrial isoform 
of aldehyde dehydrogenase (ALDH2).6 Ethanol is eliminated from the body primarily by metabolism (95–98%) with 
small quantities being excreted via breath (0.7%), sweat (0.1%) and urine (0.3%).7
Acetaldehyde is toxic and must therefore be metabolised as soon as it is formed.6 There is considerable 
evidence that accumulated acetaldehyde contributes to tissue damage by inducing mitochondrial cell apoptosis. 
Furthermore, acetaldehyde has been reported to form adducts with dopamine, resulting in the neurotoxin salsolinol, 
which is thought to contribute towards alcohol dependence.8,9 Under normal circumstances, an estimated 1–2% 
of acetaldehyde enters the bloodstream,10 but the human body encompasses an efficient defence mechanism 
in the form of ALDH2, an enzyme with a high affinity for acetaldehyde. However, in cases of binge drinking, an 
increased concentration of blood acetaldehyde has been reported to induce acute adverse effects such as facial 
flushing, tachycardia and severe nausea.11 In some individuals, these symptoms lead to the dislike of alcohol,4 
while in others, the accumulation of acetaldehyde results in severe illness, ultimately leading to death. Therefore, it 
is of pharmacogenetics interest to investigate variation in genes coding for alcohol metabolising enzymes – ADH, 
CYP2E1, CAT and ALDH2. However, CAT was not included in the current study because it is responsible for less 
than 2% of alcohol metabolism.5 
The functions of gene variants involved in alcohol metabolism are fairly well established and their frequencies 
are reasonably documented in European and Asian populations.11,12 However, this information is lacking in South 
African populations. Although Warnich et al.13 extensively reviewed allele frequencies of various CYP enzymes in 
Bantu-speaking South Africans, CYP2E1 was omitted. However, Li et al.14 determined allele frequencies of various 
CYP2E1 polymorphisms in black male South Africans in relation to oesophageal cancer, and several other novel 
CYP variants have been observed in some South African populations.14–17 It is thus of interest to ascertain the 
frequencies of functionally significant gene variants in all South African populations in order to predict their forensic 
significance in circumstances associated with alcohol metabolism. In this pilot study, we aimed to establish 




The cohort consisted of 150 control subjects from four South African population groups: Xhosa (n=34), Zulu 
(n=40), South African white (n=44) and South African coloured (n=32). Ethnicity of individuals was self-reported 
and informed consent was obtained from all participants. For the purposes of this study, the South African white 
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some individuals in the South African coloured group exhibit mixed 
ancestry. The study was carried out according to the Declaration of 
Helsinki (2008) and was approved by the University of Cape Town’s 
Research Ethics Committee (REC REF: 103/2009).
Genotyping 
Candidate genes that are involved in alcohol metabolism and their 
variants were identified using published literature14,18 and data from 
the 1000 Genomes Project (http://www.1000genomes.org/)19. ADH1B 
rs1229984G>A (p.Arg49His), ADH1B rs2066702C>T (p.Arg370Cys), 
CYP2E1 rs3813867G>C, CYP2E1 rs2031920C>T, CYP2E1 
rs6413432T>A and ALDH2 rs671G>A (p.Glu504Lys) were selected. 
Fragments containing the SNPs of interest were amplified using the 
polymerase chain reaction (PCR). Each PCR mixture contained 100 ng 
DNA, 5 X Green GoTaq® reaction buffer (Promega, Madison, WI, USA), 
0.5 U Taq polymerase (Promega, Madison, WI, USA), 0.2 mM of each 
dNTP (Bioline, London, UK) and 0.4 µM of each relevant primer (Table 1) 
in a total volume of 25 µL.20-22 Typical cycling conditions were followed.
Table 1:  Primers used for polymerase chain reaction (PCR)
Gene SNP Primer sequence Reference























SNPs were genotyped using SNaPshot PCR, except for rs6413432 
which was genotyped using restriction fragment length polymorphism 
(RFLP) with the restriction enzyme Dra1. SNaPshot PCR was carried out 
on cleaned, pooled PCR products, relevant SNaPshot primers (Table 2) 
and 1 µL Applied Biosystems SNaPshot® Multiplex Ready Reaction Mix 
(Applied Biosystems, Carlsbad, CA, USA) in a total volume of 10 µL. 
All SNaPshot reactions were carried out on the GeneAmp PCR System 
9700 (Applied Biosystems, Carlsbad, CA, USA) and cycled 25 times at 
96 °C for 10 s, 50 °C for 5 s and 60 °C for 30 s. Samples underwent 
capillary electrophoresis on the ABI PRISM® 3100 Genetic Analyzer 
(Applied Biosystems, Carlsbad, CA, USA) in the presence of GeneScanTM 
120 LIZ® Size Standard (Applied Biosystems, Carlsbad, CA, USA). 
GeneMapperTM v3.0 (Applied Biosystems, Carlsbad, CA, USA) software 
was used to analyse peaks and genotypes of samples.
For the RFLP, samples were digested with 1 U FastDigest® Dra1 
(Fermentas, Ontario, Canada) and 10X FastDigest® Green Buffer 
(Fermentas, Ontario, Canada) in a final volume of 30 µL and incubated 
at 37 °C for 1 h. Of the total cohort, 10% was sequenced to verify 
SNaPshot PCR and RFLP results, whereby at least one representative 
of each genotype was included for each SNP. Each population was 
represented in this selection.
Statistics
Genotypes for every SNP within each population group were tested for 
deviation from Hardy–Weinberg equilibrium. Fisher’s exact tests were 
performed to examine whether there were differences in the allelic 
frequencies between each of the population groups under study, for each 
SNP independently. The online bioinformatic tool SHEsis (http://analysis.
bio-x.cn/SHEsisMain.htm) was used to analyse linkage disequilibrium 
(LD) between the SNPs under investigation. The SHEsis platform uses 
a full-precise-iteration algorithm which calculates the probability of 
the SNPs of interest being inherited together, based on the genotype 
input data.23,24 
Results
All SNPs were in Hardy–Weinberg equilibrium for each population group. 
Allele frequencies for the six SNPs under investigation are presented 
in Table 3.19 The South African coloured population exhibited the most 
heterozygosity for the six SNPs while the Zulu population exhibited 
the least. 
Genotypes for ADH1B rs1229984G>A and rs2066702C>T were 
analysed in combinations of the previously reported haplotypes 
ADH1B*1, ADH1B*2 and ADH1B*3 (Table 4).25 All three haplotypes 
were observed in the Xhosa, South African white and South African 
coloured populations, but the ADH1B*2 haplotype was absent in 
the Zulu population. ADH1B*1 was the most frequent haplotype in 
each population.
Similarly, genotypes for CYP2E1 rs3813867G>C, rs2031920C>T and 
rs6413432T>A were grouped together into the haplotypes CYP2E1*1A, 
CYP2E1*5A, CYP2E1*5B and CYP2E1*6 (http://cypalleles.ki.se/
cyp2e1.htm) (Table 4). In a total of six cases, CYP2E1 rs3813867 was 
heterozygous G/C while CYP2E1 rs2031920 and rs6413432 were both 
homozygous (i.e. rs2031920C/C and rs6413432T/T). This combination 
of nucleotides (i.e. rs3813867G/C, rs2031920C/C and rs6413432T/T) 
did not fall into a previously reported haplotype and was noted in a 
separate row in Table 4. 
The CYP2E1*1A haplotype was the most common in all four populations, 
followed by CYP2E1*6. The CYP2E1*5A haplotype occurred in a single 
individual in the South African white population while CYP2E1*5B did 
not appear in any population. The newly observed combination of 
nucleotides occurred in each of the populations being studied and had 
the highest relative frequency (0.07) in the Xhosa population. 
When comparing allele observations in a pairwise fashion between the 
four population groups, three significant results were obtained. The 
Zulu and the South African coloured population groups had significantly 
different allele frequencies for ADH1B rs1229984A (p=0.009). The 
ADH1B rs2066702T variant frequency differed significantly between the 
Xhosa population group and the South African white population group 
(p=0.034). Allele frequencies for CYP2E1 rs6413432 were significantly 
different between the Zulu and South African white populations 
Table 2:  Internal primers used for SNaPshot reactions
Gene SNP Primer (5` → 3`) Orientation
ADH1B rs1229984 ATAAGTGGCTGTAGGAATCTGTC Forward
rs2066702 TAACCACATATATTCCTATTGCAG[T/C]ATC Forward
CYP2E1 rs3813867 GGGCTTGGTTCAGGAGAG Forward
rs2031920 AAAACTATACATAAAGATTCATTGTTAATATAAAAGTA Forward
ALDH2 rs671 AATAACAATAATATACACTCACAGTTTTCACTT Reverse
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(p=0.030). However, the observed allele frequency distributions were 
no longer significantly different when the Bonferroni correction for 
multiple testing was applied. 
The online bioinformatic tool SHEsis was used to analyse LD between 
the SNPs in CYP2E1 (Figure 1). The numbers in the blocks within Figure 
1 indicate a LD score (D’), whereby an LD score of 100 indicates 
complete LD. The p-values in brackets indicate the level of significance 
of the score, calculated using Fisher’s exact test. 
Discussion
Pharmacogenetics has potential in the clinical setting in which drugs are 
dispensed for the treatment of disease; however, its use can be extended 
to aid forensic science, especially in the context of post-mortem in 
suspected drug-associated deaths. Individuals are frequently exposed 
to substances which have the capacity to cause death and whose 
metabolism is influenced by the genetic variants in their metabolising 
enzyme genes. The utility of pharmacogenetics in forensic science lies in 
its ability to reduce the miscategorisation of deaths previously classified 
as sudden unexpected deaths by identification of the associated gene 
variants that affect metabolism and lead to such deaths. In this study, 
we aimed to establish the baseline frequencies of variants within genes 
involved in alcohol metabolism within four South African populations – 
Xhosa, Zulu, South African white and South African coloured – for future 
use in predicting possible differences among the population groups in 
their disposition to alcohol. 
Such variants are of forensic relevance as they may help in classifying 
the manner in which a person might have died. For example, if a post-
mortem reports a lethal amount of alcohol in the deceased, it may 
not be readily possible to conclude whether the manner of death was 
suicidal or accidental26; but the presence of a gene variant associated 
with accumulation of the particular drug (e.g. ethanol) may point to 
unintentional accumulation (e.g. of acetaldehyde) and ultimately to 
accidental death. However, if the individual had a gene variant that 
resulted in normal metabolism of ethanol, the manner of death would 
Table 3:  Distribution of allele frequencies in the four South African population groups, the 1000 Genome Project and two HapMap3 populations
ADH1B CYP2E1 ALDH2 
rs1229984 rs2066702 rs3813867 rs2031920 rs6413432 rs671
Allele A T C T A A
Xhosa  
(n=34;33;30;30;33;34)
0.03 0.12 0.03 0.00 0.05 0.00
Zulu  
(n=34;30;37;37;37;40)
0.00 0.10 0.01 0.00 0.03 0.00
South African white 
(n=29;30;36;36;36;42)
0.03 0.02 0.04 0.01 0.13 0.00
South African coloured 
(n=30;30;31;31;31;32)
0.10 0.05 0.02 0.00 0.15 0.02
1000 Genome Project  
(phase 1 populations)
0.21 0.05 0.10 0.09 0.16 0.06
HapMap3  
Yoruba
0.00 0.27 0.00 0.07 0.00 0.09
HapMap3  
Caucasian
0.00 0.00 0.00 0.07 0.06 0.14
Table 4:  Frequencies of ADH1B and CYP2E1 haplotypes in the four South African populations
Haplotype Single nucleotide polymorphisms (SNPs) Population
SNP 1 SNP 3 SNP 3 Xhosa Zulu South African white South African coloured
rs1229984 (G>A) rs2066702 (C>T) N/A
ADH1B*1 G C N/A 0.73 0.8 0.9 0.73
ADH1B*2 A C N/A 0.03 0 0.07 0.2
ADH1B*3 G T N/A 0.24 0.2 0.03 0.07
rs3813867 (G>C) rs2031920 (C>T) rs6413432 (T>A)
CYP2E1*1A G C T 0.86 0.92 0.73 0.71
CYP2E1*5A C T A 0 0 0.03 0
CYP2E1*5B C T T 0 0 0 0
CYP2E1*6 G C A 0.07 0.06 0.18 0.26
New haplotype C C T 0.07 0.03 0.06 0.03
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most likely be considered suicide. It has to be kept in mind that 
substances that inhibit or induce these enzymes are also likely to have 
similar effects as variant alleles. Therefore, after genotype or phenotype 
studies, SNPs known to affect metabolism of drugs suspected to have 
been taken by the deceased, could be recommended for inclusion in a 






















Figure 1:  Linkage disequilibrium scores (D’) between rs3813867, 
rs2031920 and rs6413432 in CYP2E1. Complete LD is 
observed where the LD score is 100. Complete linkage 
equilibrium is observed where the LD score is 0.
Of these SNPs with forensic relevance, the South African coloured 
group exhibited the most heterozygosity and was the only population 
group to show variation in ALDH2 rs671. However, this finding needs 
to be confirmed by comparing the distribution of this variant among 
South African coloured individuals whose deaths were alcohol related 
and those who drank but whose deaths were not alcohol dependent. 
Other populations showed relatively little variation in these SNPs; for 
example,  the Zulu population group exhibited variation only in ADH1B 
rs2066702 (10%), CYP2E1 rs3813867 (1%) and CYP2E1 rs6413432 
(3%). With respect to ADH1B, the Zulu group presented with more of 
the slow ethanol-metabolising variants than the variants associated with 
fast metabolism. 
No individual in the entire cohort contained variants for both ADH1B 
rs1229984A and ADH1B rs2066702T, which is consistent with the 
literature to date.20 It can be speculated that either the SNPs are in 
complete LD or that having both nucleotide changes is incompatible 
with life. 
Although the possibility exists that CYP2E1 haplotypes with different 
combinations of the three SNPs (rs3813867 (G>C), rs2031920 (C>T) 
and rs6413432 (T>A)) could occur, current literature does not provide 
evidence for this. Watanabe et al.27 demonstrated that rs3813867G and 
rs2031920C are in complete LD. However, a different combination of 
variants (CYP2E1 rs3813867G/C, CYP2E1 rs2031920C/C) was detected 
in six individuals in this study, suggesting that a recombination event 
might have occurred that resulted in the novel haplotype. 
One can speculate that if the rs2031920T allele leads to increased 
transcriptional activation of CYP2E1, and the rs3813867C polymorphism 
has little effect on transcription,28 individuals with the novel allele 
detected in this study could more likely display CYP2E1 activity within 
the normal range. However, functional studies would be needed to 
confirm this speculation. 
The outcome of SHEsis indicated a D’ value of 99 for SNPs rs2031920 
and rs3813867, indicating that the SNPs are in almost complete LD 
(p<0.001). The disruption of the former haplotype could be a result 
of a recombination event and occurred at low frequencies (≤ 7%) in 
all four population groups in the study. Non-African populations are 
known to have larger haplotype blocks as a result of founder effects 
subsequent to migration out of Africa. Since the out of Africa migration, 
fewer recombination events have occurred as there have been fewer 
generations from the new founder group. As a consequence, larger 
haplotype blocks are inherited by successive offspring,29 which may 
explain the presence of the novel allele in the Xhosa and Zulu populations. 
In the South African coloured group, the novel allele could be a result of 
admixture, resulting in gene flow between black South Africans, the San, 
the Khoikhoi, western Europeans, Indonesians and Indians who settled 
in the Cape in the 17th century.30 Therefore, if the recombination event 
occurred in the African ancestor and the allele was passed to the South 
African coloured individual in this way, the presence of the novel allele 
in the South African coloured population is explained. However, this 
explanation is unlikely as the frequency for the novel allele is second 
highest for the South African white population group who are of European 
descent. Rather, a second recombination event could have occurred in 
the European population group after the out of Africa migration, resulting 
in the South African coloured group inheriting the allele from the South 
African white population.
A heritage analysis by Greeff in 2007 revealed that the Afrikaner population 
also has numerous contributors of genes, including Madagascans, 
African slaves and Indians,31 which could possibly account for the 
presence of the haplotype in the South African white population. 
Lee et al.32 undertook a comprehensive study and reported global 
patterns of allele and haplotype frequencies in CYP2E1. They genotyped 
11 polymorphisms across CYP2E1 in 50 population groups and showed 
that allele, haplotype and LD patterns varied greatly among geographical 
regions. Lee et al.32 identified extensive genetic variation in Africa 
and reported 16 common haplotypes in addition to various residual 
haplotypes. An in-depth and direct comparison of haplotype results 
cannot be made as classification of haplotypes by Lee et al.32 was not 
done according to the CYP allele database (http://www.cypalleles.ki.se/), 
as was done here. However, the CYP2E1 SNPs in this study correspond 
to markers 2 (rs3813867), 3 (rs2070672) and 9 (rs6413432) in Lee 
et al.’s32 study and fall into ‘core groups’ A, A and B, respectively. The 
proposed recombination event in this study was between markers 2 and 
3, both of which were grouped into core A by Lee et al.32 It therefore 
seems unlikely that the novel haplotype proposed in this study has been 
previously observed, as they both form part of the same core group in 
this global study.
A limitation of this study was the small sample sizes used for each 
population group, which may have resulted in an inflation of statistical 
type 1 and type 2 errors. Furthermore, the self-reported ethnicity of 
participants also poses a limitation, as baseline frequencies may not 
have been truly representative of the actual populations. This method 
was deemed suitable for this pilot study, but a more reliable method to 
determine ethnicity should be included in subsequent studies. 
Baseline frequencies for six informative polymorphisms in genes 
involved in alcohol metabolism were obtained for four South African 
populations: Xhosa, Zulu, South African white and South African 
coloured. The findings reported here add to knowledge in the field, offer 
a potential utility in the forensic setting and provide a platform for future 
studies in the area. 
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